RPG Life Sciences Limited — Board Meeting, 07-11-2024: Outcome of Board Meeting

RPG Life Sciences Limited's Board has approved the unaudited financial results for the quarter and half-year ending September 30, 2024. Total revenue was ₹17,415 lakhs, with a profit before tax of ₹1,509 lakhs, after accounting for exceptional items of ₹2,730 lakhs. The profit for the period stands at ₹420 lakhs, with earnings per share of ₹2.54. The company confirmed its sole operational segment as Pharmaceuticals and reclassified certain assets as held for sale.